Page last updated: 2024-12-06
tetrabutoxy titanium
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
tetrabutoxy titanium: RN given refers to monomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 21801 |
| MeSH ID | M0167260 |
Synonyms (50)
| Synonym |
|---|
| butyl alcohol, titanium(4+) salt |
| butyl titanate(iv), (buo)4ti |
| titanium tetrabutoxide |
| tyzor tbt |
| butyl titanate(iv) |
| titanium, tetrabutoxy- |
| titanic acid, tetrabutyl ester |
| butyl orthotitanate |
| titanium tetrabutylate |
| nsc-59799 |
| tyzor bp |
| 1-butanol, titanium(4+) salt |
| tetrabutyl titanate |
| titanium butoxide (ti(obu)4) |
| titanium(iv) n-butoxide |
| tetrabutyl orthotitanate |
| 5593-70-4 |
| nsc-220232 |
| hsdb 839 |
| orgatics ta 25 |
| butyl titanate monomer |
| butyl titanate |
| titanium(4+) butoxide |
| titanium tetrakis(butoxide) |
| nsc 59799 |
| einecs 227-006-8 |
| orthotitanic acid, tetrabutyl ester |
| titanium butylate |
| tetrabutoxy titanium |
| titanium tetrabutanolate |
| tetrabutyltitanate [czech] |
| 1-butanol titanium(4+) salt |
| b 1 (titanate) |
| nsc 220232 |
| titanium butoxide |
| tetrabutoxy titan |
| B0742 |
| 9022-96-2 |
| fjs8q2mx9i , |
| unii-fjs8q2mx9i |
| ec 227-006-8 |
| 1-butanol, titanium(4+) salt (4:1) |
| tetrabutoxy titanium [hsdb] |
| AKOS025243244 |
| DTXSID6041262 |
| orthotitanic acid tetrabutylester |
| FT-0699968 |
| Q4456610 |
| 4-(2,5-dimethyl-1h-pyrrol-3-yl)pyridine |
| butan-1-olate;titanium(4+) |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.21
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.21) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||